ZTQ-29623-67067
2 vaccinations
3 coded responses
17 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 054 / VT
- Registered
- 2020-12-20
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2020-12-20
Registered in v-safe
-
2020-12-20
Dose 1 — Pfizer-BioNTech
-
2020-12-20
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2020-12-21
- 2020-12-22
- 2020-12-27
- 2021-01-03
-
2021-01-10
Dose 2 — Pfizer-BioNTech
- 2021-01-13
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-24
- 2021-01-31
- 2021-02-07
-
2021-02-14
Survey response — day 35, dose 2MedDRA: Cardiac disorder, Hypoplastic left heart syndrome, Pregnancy — Feeling: Good · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Pregnancy diagnosed with major cardiac defect, likely hypoplastic left heart syndromeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-14
Report sent to call center — day 35, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-21
Survey response — day 42, dose 2MedDRA: Foetal cardiac disorder, Hypoplastic left heart syndrome — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Fetus diagnosed with hypoplastic left heart syndromeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-21
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-13
-
2021-04-11
Survey response — 3 months, dose 2MedDRA: Abortion induced, Surgery — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Termination of pregnancy due to complex fetal cardiac anomaly · Healthcare visit (other): Outpatient surgeryMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-11
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-14
- 2022-01-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-20 | Pfizer-BioNTech | |
| 2 | 2021-01-10 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-14 | Unsuccessful | |
| 2021-02-21 | Unsuccessful | |
| 2021-04-11 | Unsuccessful |
Free text
Release 4 — day 35, dose 2
Symptoms: Pregnancy diagnosed with major cardiac defect, likely hypoplastic left heart syndrome
Release 4 — day 42, dose 2
Symptoms: Fetus diagnosed with hypoplastic left heart syndrome
Release 7 — 3 months, dose 2
Symptoms: Termination of pregnancy due to complex fetal cardiac anomaly
Healthcare visit (other): Outpatient surgery
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Surgery | ✓ | ✓ | ✓ |
| SD | Abortion induced | ✓ | ✓ | ✓ |
| SD | Cardiac disorder | ✓ | ✓ | ✓ |
| SD | Foetal cardiac disorder | ✓ | · | ✓ |
| SD | Hypoplastic left heart syndrome | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release